β-amyloid catabolism: Roles for neprilysin (NEP) and other metallopeptidases?

Journal of Neurochemistry

Volumn 81, Issue 1, 2002, Pages 1-8

  Carson, Julie A ^a   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Amyloid; Endopeptidase; Insulysin; Neprilysin; Neurodegeneration; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; GAMMA SECRETASE; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; PLASMIN; PROTEINASE; THIMET OLIGOPEPTIDASE;

ALZHEIMER DISEASE; BIOSYNTHESIS; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASPARTIC ENDOPEPTIDASES; HUMANS; INSULYSIN; METALLOENDOPEPTIDASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEPRILYSIN; NERVOUS SYSTEM; PEPTIDE FRAGMENTS;

EID: 0036077536     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.00855.x     Document Type: Review

References (78)

1. Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts
2. Differential response of neutral endopeptidase 24.11 ('enkephalinase'), and cholinergic and opioidergic markers to hypoglosssal axotomy
3. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40)
4. Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus
5. Membrane localisation of endopeptidase-24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain. A study using subcellular fractionation and electron microscopic immunocytochemistry
6. Insulin-degrading enzyme in the Alzheimers disease brain: Prominent localization in neurons and senile plaques
7. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
8. A study of French centenarians: Are ACE and APOE associated with longevity
9. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family
10. Expression of HLC-DR and common acute lymphoblastic leukemia antigens on glioma lines
11. The multiple paradoxes of presenilins
12. Degradation of the Alzheimer's amyloid β peptide by endothelin-converting Enzyme
13. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)
14. Endothelin-converting enzyme 2 is a membrane bound, phosphoramidon sensitive metalloprotease with an acidic pH optimum
15. Plasmin cleaves Aβ42 in vitro and prevents its aggregation into β-pleated sheet structures
16. Intracellular production of beta A4 amyloid of Alzheimer's disease: Modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein
17. Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family
18. Alzheimer's disease: Initial report of the purification and characterisation of a novel cerebovascular amyloid protein
19. Novel activity of endothelin-converting enzyme: Hydrolysis of bradykinin
20. The search for α-secretase and its potential as a therapeutic approach to Alzheimer's disease
21. Neutral endopeptidase can hydrolyze β-amyloid (1-40) but shows no effect on β-amyloid precursor protein metabolism
22. In search of an enzyme: The beta-secretase of Alzheimer's disease is an aspartic proteinase
23. Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ), retards Aβ aggregation, deposition, fibril formation and inhibits cytotoxicity
24. Identification of a novel aspartic protease (Asp 2) as beta-secretase
25. Molecular identification and characterisation of a novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides
26. Metabolic regulation of brain Aβ by neprilysin
27. Identification of the major Aβ1-42 degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
28. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin
29. A full genome scan for late onset Alzheimer's disease
30. Cellular reorganization of membrane peptidases in Wallerian degeneration of pig peripheral-nerve
31. Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers
32. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme
33. Insulin-degrading enzyme: Embarking on amyloid destruction
34. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
35. Brain plasmin enhances APP α-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains
36. The common acute lymphoblastic leukemia antigen is identical to neutral endopeptidase
37. Superoxide regulation of endothelin-converting enzyme
38. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11
39. Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y
40. Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized protein
41. Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are co-ordinately induced in neurons and astrocytes following nerve injury
42. Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon
43. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
44. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments
45. Phosphoramidon-sensitive endothelin-converting enzymes modulate cerebral blood flow and neural damage of hypoxic rats
46. Degradation of soluble amyloid β-peptides 1-40, 1-42 and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains
47. Presenilin 1 over-expression accelerates the degradation of Aβ by insulin degrading enzyme
48. Insulin degrading enzyme regulates extracellular levels of amyloid β-protein by degradation
49. Impaired ventilatory responses to hypoxia in mice deficient in endothelin-converting-enzyme-1
50. Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A
51. Insulysin
52. A monoclonal antibody to common acute lymphoblastic leukaemia antigen (neutral endopeptidase) immunostains senile plaques in the brains of patients with Alzheimer's disease
53. Genetic associations with human longevity at the APOE and ACE loci
54. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
55. Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family
56. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells
57. Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases
58. Purification and cloning of amyloid precursor protein beta-secretase from human brain
59. The role of presenilins in γ-secretase activity: Catalyst or cofactor
60. Analysis of the subsite specificity of rat insulysin using fluorogenic peptide substrates
61. Purification and characterization of endothelin-converting enzyme from rat lung
62. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β Peptide in the brain
63. Neprilysin II. A putative novel metalloprotease and its isoforms in CNS and testis
64. The plasmin system is induced by and degrades amyloid-beta aggregates
65. The angiotensin converting enzyme gene family: Genomics and pharmacology
66. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
67. The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
68. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter. Molecular cloning and characterization
69. Organisation and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respiration
70. Plasmin cleavage of the amyloid β-protein: Alteration of secondary structure and stimulation of tissue plasminogen activator activity
71. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
72. Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme
73. Presenilin and γ-secretase: Structure meets function
74. Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation
75. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity
76. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides
77. Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of β-amyloid peptide
78. Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type